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Major structural cardiovascular diseases are associated with cardiac arrhythmias, but their full 
spectrum remains unknown in sub-Saharan Africa (SSA), which we addressed in this systematic 
review. Atrial fibrillation/atrial flutter (AF/AFL) prevalence is 16–22% in heart failure, 10–28% 
in rheumatic heart disease, 3–7% in cardiology admissions, but <1% in the general population. 
Use of oral anticoagulation is heterogenous (9–79%) across SSA. The epidemiology of sudden 
cardiac arrest/death is less characterized in SSA. Cardiopulmonary resuscitation is challenging, 
owing to low awareness and lack of equipment for life-support. About 18% of SSA countries 
have no cardiac implantable electronic devices services, leaving hundreds of millions of people 
without any access to treatment for advanced bradyarrhythmias, and implant rates are more 
than 200-fold lower than in the western world. Management of tachyarrhythmias is largely non-
invasive (about 80% AF/AFL via rate-controlled strategy only), as electrophysiological study and 
catheter ablation centers are almost non-existent in most countries.
Highlights:
-  Atrial fibrillation/flutter prevalence is 16–22% in heart failure, 10–28% in rheumatic heart 
disease, 3–7% in cardiology admissions, and <1% in the general population in sub-Saharan 
Africa (SSA).
-  Rates of oral anticoagulation use for CHA2DS2VASC score ≥2 are very diverse (9–79%) 
across SSA countries.
-  Data on sudden cardiac arrest are scant in SSA with low cardiopulmonary resuscitation 
awareness.
-  Low rates of cardiac implantable electronic devices insertions and rarity of invasive 
arrhythmia treatment centers are seen in SSA, relative to the high-income countries.
Keywords: atrial arrhythmias; supraventricular tachycardia; sudden cardiac death; ventricular 
arrhythmias; pacemaker; defibrillator; sub-Saharan Africa
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Introduction
About 1.1 billion people live in 49 countries of sub-Saharan Africa (SSA) accounting for approximately 15% 
of the world population [1]. Historically, the leading causes of mortality in SSA have been communicable 
diseases, and non-communicable diseases (NCDs) were not considered to be a public health priority [2, 3]. 
However, it is now clear that the burden of NCDs has long been an endemic problem in SSA [3–6]. NCDs 
are projected to overtake infectious diseases and account for more than half of all deaths by 2030 in SSA 
[7]. Among NCDs, cardiovascular diseases (CVDs) are the leading cause of death accounting for 37% of all 
NCDs deaths and approximately 13% of all deaths in SSA [3]. Approximately 32 million people in SSA are 
currently living with some form of diagnosed CVD and it is estimated that there are many more living with 
undiagnosed CVD, and 3.6 million incident cases are reported annually [2, 3].
All major structural CVDs are associated with cardiac arrhythmia. Therefore, it is likely that the grow-
ing burden of CVDs in SSA also reflects the growing burden of cardiac arrhythmias, though the full spec-
trum is poorly characterized. Prior reviews have described the epidemiology of atrial fibrillation in Africa 
[8]. However, it remains uncertain as to whether atrial fibrillation/atrial flutter (AF/AFL), supraventricular 
tachycardias (SVTs), significant bradyarrhythmias, ventricular tachycardia/ventricular fibrillation (VT/VF), as 
well as sudden cardiac arrest/sudden cardiac death (SCA/SCD) are regularly diagnosed and treated in SSA. 
Ascription of SCD among some SSA populations to non-medical causes like witchcraft is not uncommon 
[9]. Nonetheless, arrhythmias are probably underdiagnosed in SSA due to lack of equipment and expertise 
[10]. Few informative surveys and reviews on the status of arrhythmia services in Africa have revealed severe 
deficiencies in healthcare systems and arrhythmia specialists [9, 11–14]. However, a detailed description 
of clinical arrythmia entities in SSA is lacking. This systematic review will therefore assess the distribution, 
etiologies, diagnosis, and treatment of arrhythmias in tandem arrythmia services in SSA. It will also compare 
these with high-income countries (HIC) of Western Europe and North America, identify possible contribu-
tors to any under-diagnosis and under-treatment, and provide some recommendations.
Methods
We systematically searched the PubMed/MEDLINE, Excerpta Medica Database (EMBASE), and African 
Journals Online (AJOL), to identify all relevant studies published until March 31st, 2019 and restricted to 
humans, reporting on cardiac arrhythmias in SSA, without language restriction. The search strategy and 
terms used were as follows: 1) Atrial fibrillation OR atrial flutter AND Africa; 2) supraventricular tachycardia 
OR atrioventricular nodal reentry tachycardia OR atrial tachycardia OR atrioventricular reentry tachycardia 
OR Wolff-Parkinson-White syndrome AND Africa; 3) sudden cardiac arrest OR sudden cardiac death OR ven-
tricular arrhythmia OR ventricular tachycardia OR ventricular fibrillation AND Africa; and 4) bradycardia 
OR pacemaker OR defibrillator OR cardiac implantable electronic devices AND Africa. Sub-Saharan African 
studies were then filtered from the identified studies. Inclusion criteria for AF/AFL and SVTs were stud-
ies reporting prevalence, risk factors, arrhythmia treatment, oral anticoagulation, and follow-up outcome. 
Inclusion criteria for SCA/SCD were studies reporting out-of-hospital cardiac arrest (OHCA) or in-hospital 
cardiac arrest (IHCA), attempted cardiopulmonary resuscitation (CPR), return of spontaneous circulation 
(ROSC), and survival. Manual searches of references of published articles were also undertaken. We excluded 
editorials, commentaries, letter, notes, conference abstracts without full published articles, and narrative 
reviews (See Figure 1). Data extraction and quality assessment were meticulously done according to set 
criteria by two authors (MFY & MN) independently. The marked heterogeneity of studies among specific 
arrhythmia entities precluded any meta-analysis.
Results
As shown in Figure 1, the initial PubMed/Medline, EMBASE, and AJOL search restricted to humans till 
March 31st, 2019 and manual searches of references of published articles for AF/AFL, revealed 1,036 cita-
tions. When narrowed to SSA with exclusion of duplicates, editorials, letters, reviews, conference abstracts 
without full article publications, and commentaries, they were 343 remaining abstracts to screen, of which 
43 made the inclusion criteria and 23 studies had compatible data to be entered in Table 1. For SVTs, the 
final number of abstracts reviewed was 20, and only two studies were suitable. The search for SCA, SCD, 
and ventricular arrhythmias, revealed 1,268 citations. After applying the exclusion criteria, there were 299 
abstracts left to screen, of which 49 made the inclusion criteria, and 14 studies had compatible data to be 
entered in Table 2. The search for articles on bradycardia and cardiac implantable electronic devices (CIEDs) 
revealed 1,450 citations, which were narrowed down to 239 abstracts via exclusion criteria (Figure 1). After 
a detailed review, 17 studies met inclusion criteria and 13 of these studies had compatible data which was 
entered in Table 4.
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Figure 2 shows an encouraging increasing trend of publications on cardiac arrhythmias in SSA over the 
past four decades, based on the studies identified for this systematic review.
Atrial fibrillation/atrial flutter (AF/AFL)
Prevalence and risk factors
Table 1 summarizes key findings from hospital-based and community-based AF/AFL studies in SSA. AF 
prevalence is low in the general population of SSA at <1% and increases with age [3, 15, 16], 3–7% in hos-
pital cardiology admissions or newly diagnosed cardiovascular diseases [17–21], 16–22% in heart failure 
patients [22, 23], 10–14% in newly diagnosed and 18–28% in established rheumatic heart disease (RHD) 
patients [24–26], 25% in patients with tuberculous pericarditis [27], 6% de novo cases post-cardiac surgery 
[28], 9.5% in pregnant women with structural heart disease [29], 2–10% of de novo stroke patients [30–
33], and varies between 25–65% in patients attending oral anti-coagulation clinics in SSA [34–36]. In SSA 
there is a high proportion of permanent AF (12–81.4% across studies) and persistent AF (9.6–70.6%), com-
pared to prevalence of paroxysmal AF (8.9–50%) [20, 37–41] as shown in Table 1. Prominent risk factors 
or comorbidities associated with AF/AFL in SSA are hypertension, which is observed in 50–87% of cases, 
heart failure 32–64%, diabetes 4–63%, RHD 15–38%, dilated cardiomyopathy 16–38%, stroke 3–40%, and 
CAD 1.2–26% of AF/AFL patients (Table 1). Other AF risk factors include non-rheumatic valvular diseases, 
smoking, obesity, obstructive sleep apnea, hyperthyroidism, COPD, congenital heart disease, and increased 
alcohol intake [15, 18–20, 28, 37, 38, 41–45]. There appears to be a female preponderance of AF/AFL in 
SSA with studies showing 40–69% of patients being females versus 31–60% males (Table 1). Studies in this 
Figure 1: Systematic search for atrial arrhythmias, sudden cardiac arrest/sudden cardiac death & ventricular 
arrhythmias, bradycardia, and cardiac implantable electronic devices in sub-Saharan Africa.
AF/AFL (atrial fibrillation/atrial flutter); AJOL (African Journals Online); ICD (implantable cardioverter 
defibrillator); PPM (permanent pacemaker); SVTs (supraventricular tachycardias); SCA (sudden cardiac 
arrest); SCD (sudden cardiac death); SSA (sub-Saharan Africa); VT (ventricular tachycardia); VF (ventricular 
fibrillation). Initial search restricted to human studies published up to March 31st, 2019. *Studies not 
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region have shown that the presence of AF/AFL is associated prospectively with significantly high mortal-
ity (15–53%), increased rates of heart failure hospitalization, and non-fatal cardioembolic strokes during 
follow-up (10–15%) [19, 38, 46, 47].
Anticoagulation
Use of oral anticoagulation (OAC) in AF/AFL patients in SSA was noted to be very variable from 9–79% 
in patients with CHA2DS2VASC score ≥2 or CHADS2 score of ≥1 across studies, as shown in Table 1. In 
patients from SAA who were anticoagulated with Vitamin K antagonists, average time in therapeutic range 
(TTR) calculated by the Rosendaal method was noted to be generally low at 27–56% [24, 41, 48]. Vitamin K 
antagonist (VKA) oral anticoagulant were available in all countries surveyed recently by Pan African Society 
of Cardiology (PASCAR), while non-VKA oral anticoagulants (NOACs) were less available as follows: rivaroxa-
ban (available in 90% of countries), dagibatran (45%), apixaban (22%), and endoxaban (0%) [14].
Supraventricular tachycardias (SVTs)
From the initial citations for SVTs, only two studies all from South Africa met inclusion criteria as shown 
in Figure 1 [55, 56]. Among a pediatric population, the differential diagnoses of SVT were atrioventricular 
nodal reentrant tachycardia (AVNRT) 51%, atrioventricular reentrant tachycardias (AVRT) 24%, atrial tachy-
cardia (AT) 22%, and junctional ectopic tachycardia 3% [55]. In the other study, nine patients with Wolff-
Parkinson-White syndrome and symptomatic paroxysmal SVTs had their accessory pathways successfully 
surgically divided without complications or recurrence (four posteroseptal, three left free wall, and two right 
free wall accessory pathways) [56].
Sudden cardiac arrest/sudden cardiac death
Epidemiology and rhythm of arrest
The key finding of this systematic review is the sparsity of studies on SCA/SCD in this region. Table 2 depicts 
the few studies on SCA/SCD in SSA [57–70]. From the published studies, one of the salient findings is the 
low mean age of SCA/SCD with a range of 35–60 years across studies among adults, with higher rates in 
males compared to females in majority of studies. The reported incidences of OHCA range from 6–34 per 
100,000 inhabitants in SSA [59] [65]. The incidence of IHCA among cardiology admissions is approximately 
6% in this region [61]. The most common underlying rhythm of SCA/SCD in SSA is asystole, followed by 
pulseless electrical activity (PEA), then VT/VF, and unknown [58, 65].
Reported underlying etiologies of SCA/SCD and ventricular arrhythmias
The reported underlying etiologies of SCA/SCD and ventricular arrhythmias in SSA are shown in Table 3. 
Studies have identified hypertensive heart disease, coronary disease, cardiomyopathy, and valvular heart dis-
ease, especially rheumatic heart disease, in heterogeneous orders, as the most common causes of SCA/SCD 
among adults in SSA [61, 64, 67, 69, 71–73], while malaria was the prominent cause among the pediat-
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ric victims [57, 66]. Malignant arrhythmogenic inherited diseases have been identified in Blacks in SSA. 
Cases of hypertrophic cardiomyopathy have been reported in Black Africans [74, 75]. Little was known about 
arrhythmogenic right ventricular cardiomyopathy (ARVC) in SSA, but registry data from South Africa revealed 
similar clinical presentation and an annual SCA/SCD rate comparable to other large registries from the 
Western World [76, 77]. Brugada syndrome is associated with SCD [78, 79]. Loss-of-function CACNA1C vari-
ant, Cavα1c-T1787M, present in 0.8% of the Black African population, has recently been identified as a new 
risk factor for ventricular arrhythmias [80]. Although electrocardiographic patterns of early repolarization 
(ER) have been reported in a Black African population [81], their correlation with malignant arrythmias or 
SCA/SCD have not been studied in SSA. Notwithstanding, studies in African Americans have shown that 
the relatively high prevalence of ER in this population is not independently predictive of adverse outcomes 
[82, 83]. Ventricular non-compaction, a prominent cause of VT/VF, has been identified in patients of African 
ancestry with the prevalence of 6.9% in one cardiomyopathy clinic in South Africa [84], and in other SSA 
studies [85, 86]. Apart from one case report in a black infant [87], no other studies have documented con-
genital long QT syndrome in Black Africans. For example, a congenital long QT series of 41 patients in South 
Africa had Blacks (0%), Whites (87.8%), mixed race (9.8%), and Indian (2.5%) [74], and one other study still 
in South Africa did not mention ethnicity [88]. Acquired long-QT syndrome in heart failure cohorts has been 
associated with excess mortality [89, 90]. In patients with peripartum cardiomyopathy, prolonged corrected 
non-congenital QT interval and sinus tachycardia on baseline ECG were independent predictors of poor 
composite outcome which included death during follow-up [90].
Table 3: Reported underlying etiologies of sudden cardiac arrest/sudden cardiac death among adults in 
sub-Saharan Africa.
Cardiomyopathies [58, 61]
Hypertensive heart disease [58, 62, 67]
Coronary artery disease [58, 59, 61, 64, 69]
Rheumatic heart disease [61, 69]
Congenital heart disease [96]
Arrhythmogenic right ventricular cardiomyopathy [76, 77]
Hypertrophic cardiomyopathy [74, 75]
Brugada syndrome [78, 79]
Congenital Long QT syndrome (seen only in non-Black populations) [74, 88, 101]
Ventricular non-compaction [84]
Pulmonary embolism [62, 91]
Endomyocardial fibrosis [95]
Pulmonary hypertension [61]
Pericarditis (mainly tuberculous) [92]
Aortic dissection/rupture [64]
Endemic parasitic infections like trypanosomiasis & schistosomiasis [9, 59, 93]
Sarcoidosis [102–104]




Tuberculosis [58, 64, 70]
Renal disease [58, 64]
Liver disease [58, 64]
N/B: Detailed investigations for the cause of SCA/SCD are sparse in SSA. Therefore, uncertainty remains about the rela-
tive frequencies of these underlying etiologies.
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Reports of SCA/SCD due to pulmonary embolism [62, 91], pulmonary hypertension [61], and aortic dissec-
tion/rupture [64] are seen. Pericarditis, especially tuberculous which accounts for about 65–91% of all peri-
carditis cases in SSA, is associated with premature death [92]. Some endemic parasitic infections have been 
identified as potential causes of arrhythmias and conduction abnormalities. These include trypanosomiasis-
induced cardiomyopathy through chronic pan-carditis (Trypanosoma brucei which is of the same genus as 
Trypanosoma cruzi which causes Chagas disease in Latin America), and schistosomiasis-induced pulmonary 
hypertension leading to right sided cardiomyopathy plus arrhythmias, amebiasis, toxoplasmosis, among 
others [9, 93]. There have been case reports of SCA/SCD events with use of an antimalarial, halofantrine 
[94]. Endomyocardial fibrosis which is endemic in SSA has very poor prognosis with survival after diagnosis 
reported to be two years due to malignant arrhythmias, heart failure, and thromboembolism [95]. SCA/SCD 
due to congenital heart disease has been reported in SSA [96]. Short QT syndrome, catecholaminergic poly-
morphic ventricular tachycardia (CPVT), and other VTs forms have not been observed in the SSA literature.
Cardiopulmonary resuscitation (CPR)
As shown in Table 2, there is an alarming observed gross lack of CPR awareness among the SSA popula-
tions. CPR was only attempted in 3.7–40% of OHCA and only attempted in about 50% of IHCA cases among 
adults [59, 61, 65], in non-perioperative studies. Excluding perioperative cardiac arrest, ROSC was achieved 
in <20% of adult SCA cases and survival to discharge was low at <5%. The best predictor of ROSC was a 
shockable rhythm (VT/VF), followed by PEA, with asystole having the worse outcomes [58, 65]. Multiple 
surveys in SSA have demonstrated that even clinicians including physicians do not have adequate basic 
life support (BLS) and advanced cardiac life support (ACLS) training (about half of those surveyed), and the 
majority are unable to operate an automated external defibrillator (AED) [13, 97, 98]. In South Africa where 
EMS services are available, overall knowledge and skill performance of CPR is still well below standard by 
EMS personal with only 25% of the required standards met [99]. In addition to lack of optimal resuscitative 
measures, quality improvement schemes are also deficient in SSA. A survey of 17 hospitals in SSA found that 
only 20% of these had a cardiac arrest response team system, only 21% documented CPR events, and only 
21% reviewed such events for education and quality improvement [100].
Bradyarrhythmias and cardiac implantable electronic devices (CIEDs)
Indications of device implantation, type of device
Seventeen studies on bradyarrhythmias and CIEDs in SSA were identified through the systematic search [9, 
11, 12, 105–119] (Figure 1). Table 4 depicts 13 of these studies with some uniform data that could be organ-
ized into one table. The commonest indication for permanent pacing in SSA is atrioventricular block (AVB) 
accounting for 45–100% of all cases across studies, compared to sick sinus syndrome at 0–35%, and others 
(atrioventricular node ablation, cardiac re-synchronization therapy, etc) 0–20%. Single chamber ventricular 
(VVI) pacemakers are the most frequently implanted (17–87%), compared to dual chamber (12–82%), and 
others like atrial-sensed ventricular-paced (VDD) (0–15%) [107–117, 120]. Cost constraints have been identi-
fied as the reason for high implant percentage of VVI compared to DDD [114].
Implantation rates of pacemakers and defibrillators plus complications
Epidemiological survey data emanating from SSA indicate that there are still countries without a CIEDs 
implanting center, and a patchy presence in others. The first report of the PASCAR on the statistics of the 
use of CIEDs and ablation procedures revealed that 26% of the 31 countries surveyed did not perform any 
permanent pacemaker (PPM) implantations. The median pacemaker implantation rate was 2.66 per million 
population per country, median number of PPM implantation centers was 0.14 per million inhabitants and 
0.10 operators per million population. Implantable cardioverter-defibrillator (ICD) and cardiac resynchroni-
zation therapy (CRT) were performed in 39% and 48% countries respectively, mostly by humanitarian visit-
ing cardiac teams from abroad. Rates of centers performing ICD and CRT were similar and ranged from 0.02 
to 1.59 per million population [11, 12]. In a more recent second report of PASCAR survey (2011–2018), 18% 
of countries in this region still did not perform PPM implantations, and implantation and operator rates 
rate were 2.79 and 0.772 per million population respectively in implanting countries. ICD and CRT were 
performed in 65% and 52% countries respectively, while reconditioned CIEDs were used in 22% countries 
[14]. In a study with long-term survival data after permanent pacing in SSA, there was a 17% mortality after 
a median follow-up time of about nine years [115]. Complications of pacing across studies are infections 
(0–6%), lead displacements (0–6%), pneumothorax (0–1.5%), hemothorax (0–1.5%), erosions (0–5.3%%), 
and death (0–2%) [107–115, 120].
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Diagnostic tools for arrhythmias
Electrocardiography (ECG) is available in all SSA countries, 2-D echocardiography in 87%, Holter ambulatory 
cardiac monitoring in 74%, exercise tolerance test in 52%, tilt table test in 13%, cardiac computed tomogra-
phy and cardiac magnetic resonance imaging available in <25% of countries, and signal average ECG is done 
only in South Africa [9, 11]. Electrical cardioversions are only done in 45% of SSA countries [12].
Antiarrhythmic medications
Recent survey of countries in Africa by PASCAR showed that digoxin and amiodarone were available in all 
surveyed countries, flecainide (80% of countries), sotalol (75%), propafenone (22%), quinidine (17%), and 
mexiletine (4% of countries) [14], and prior surveys showed that atropine and intravenous lidocaine were 
also present in some African countries [9, 11]. These findings were also observed in individual AF/AFL stud-
ies where betablockers and non-dihydropyridine calcium channel blockers are prescribed and dispensed in 
this region [18, 20, 37–39, 41, 44, 48]. There is no available information about use of adenosine to manage 
acute SVTs in this region.
Electrophysiological studies and ablations
Management of arrhythmias in SSA is largely non-invasive as electrophysiological (EP) study and catheter 
ablation centers are almost inexistent or patchy in SSA. South Africa is the only country in this region where 
complex ablations requiring 3-D mapping and transseptal puncture are performed [11, 12, 14]. Even in 
South Africa, national AF registry data showed that only 4.2% of AF patients underwent catheter ablations 
[39]. About 80% of AF/AFL patients are managed with rate control strategy across studies in SSA [18, 20, 37, 
38, 41, 44]. Figure 3 summarizes cardiac arrhythmias in SSA.
Figure 3: Central illustration of cardiac arrhythmias in sub-Saharan Africa.
CIEDs (cardiac implantable electronic devices); CPR (cardiopulmonary resuscitation); CRT (cardiac resyn-
chronization therapy); ICD (implantable cardioverter defibrillator); IHCA (in-hospital cardiac arrest); PPM 
(permanent pacemaker); OHCA (out-of-hospital cardiac arrest); ROSC (return of spontaneous circulation); 




Sudden cardiac arrest 
-Incidence: OHCA 6-34 per 
100,000 inhabitants; IHCA 6% 
cardiac admissions
-Rhythm: Most common 
underlying rhythm of SCA is 
asystole, followed by pulseless 
electrical activity (PEA), then 
VT/VF, and unknown.
-Etiologies: Hypertensive heart 
disease, coronary disease, 
cardiomyopathy, & rheumatic 
heart disease are the most 
common. Arrhythmogenic 
inherited diseases and endemic 
parasitic infections are also 
seen.
-CPR awareness: Very low, only 
attempted in 3.7- 40% of OHCA 
and in about 50% of IHCA cases 
among adults. 
-ROSC achieved in < 20% of 
adult SCA cases and survival to 
discharge low at < 5%.
Cardiac arrythmias in 
Sub-Saharan Africa
Atrial fibrillation/ Atrial flutter
-Prevalence: <1 % general 
population,16-22% in heart 
failure patients, 10-28% in 
rheumatic heart disease, 25% in 
tuberculous pericarditis, 3-7% in 
cardiology admissions, 6% de 
novo cases post-cardiac surgery, 
2-10% of de novo stroke patients.
-Oral anticoagulation for 
CHA2DS2VASC score ≥ 2: Very 
heterogenous and low rates (9-
79% across studies).
-Treatment: 80% conservative 
and mainly rate-controlled
Supraventricular tachycardia
Data almost non-existent in 
adults.
Arrhythmia diagnostic tools
-2-D echocardiography available 
in 87% of countries.
-Holter ambulatory cardiac 
monitoring available in 74%.
-Exercise tolerance test in 52%
-Tilt table test available in 13%.
-Cardiac computed tomography
and cardiac magnetic resonance 
imaging available in < 25% of 
countries.
-Signal average ECG is done 
only in South Africa.
-CIEDS implantations in 82%
-Catheter ablation centers are 
almost inexistent or patchy in 
SSA.
-3-D mapping and transseptal 
puncture are rare (done mainly in 
South Africa).
-Anti-arrhythmic medications:
Digoxin & amiodarone are 
available in all SSA countries, 
while others are present in 
patches. 
Bradyarrhythmias & CIEDS
-Pacing indication: Commonest is 
atrioventricular block accounting for 
45 -100% of all cases across 
studies, trailed by sick sinus 
syndrome.
-Type of device: Single chamber 
ventricular pacemakers are the most 
frequently implanted (up to 87%), 
trailed by dual chamber devices.
-18% of countries in SSA still do not 
perform PPM implantations
- Implant rates: PPM implantation 
and operator rates are low at 2.79 
and 0.772 per million population 
respectively. Much lower for ICD and 
CRT.
-Post-mortem CIEDs are used in 
22% countries
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Discussion
Atrial fibrillation/atrial flutter
We observed that the prevalence of AF/AFL is <1% in the general population in sub-Saharan Africa. There 
are estimated 1.3 million people with AF/AFL in SSA and according to the 2017 Global burden of Dis-
ease Study, this region has one of the lowest prevalence rates of AF/AFL at 0.13%, compared to ~1.5% in 
the high-income countries (HIC) of Western Europe and North America, but does increase with age [3]. 
Given lack of resources including ECG and ambulatory cardiac monitoring as well as the high prevalence 
of ‘highly arrhythmogenic’ conditions/risk factors/circumstances (e.g. RHD, cardiomyopathies, pericardial 
disease, unavailability of surgery, etc…), this low prevalence in SSA could represent an under-estimate. Other 
important factors include lack of healthcare access and survivorship bias i.e. lower life expectancy with com-
municable diseases. AF/AFL occurs at younger ages in SSA as seen in the RE-LY global registry, where many 
patients from SSA were younger (average age 57 years) compared to Western World (70 years) [41]. Risk 
factors of AF are similar in SSA compared to HIC, except the significantly higher prevalence of rheumatic 
heart disease in SSA (22% ) vs HIC (~2%) in AF patients observed in one large registry, as well as lower rates 
of ischemic heart disease in SSA (6%) vs HIC (~18%) [41], and high AF prevalence 25% in pericarditis in SSA 
vs 4.3% seen in pericarditis in HIC [121]. The findings of this systematic review are similar to those of prior 
reviews in Africa with respect to AF prevalences rates, risk factors, and co-morbidities [8, 122].
Despite the relatively lower prevalence of AF in people of African descent, the presence of AF is associated 
with higher rates of strokes, heart failure, and mortality compared to Caucasians, and Black patients with AF 
are much younger than patients of other races [123]. Atrial fibrillation was seen in 43–82% of patients with 
cardio-embolic strokes in SSA [40, 46]. Uncontrolled hypertension, low use of anticoagulation due less access 
and high costs (especially non-vitamin K-dependent oral anticoagulants) and poor time in the therapeutic 
range among patients on vitamin K-dependent oral anticoagulants, low use of heart failure medication, and 
late presentation with complications are plausible reasons for this increased risk of adverse outcomes. While 
anticoagulation has been shown to reduce strokes and systemic embolism as well as improve survival in 
AF/AFL patients [124, 125], its underuse is a worldwide problem [41, 126], which is even more pronounced 
in many regions of SSA [18, 20, 38, 44]. Permanent and persistent AF are more common in SSA while parox-
ysmal AF is most frequent in HIC of the Western World, suggesting that patients are presenting late in the 
natural history of the possible underlying AF-causing cardiovascular diseases in SSA [41].
This systematic review has shown that about four in five of all AF are managed via rate-control strategy. 
These findings are similar to those of one other AF review in this region [122]. This demonstrates that 
evidenced-based AF rhythm-control strategies with catheter ablations which have been shown to have a 
survival benefit in AF patients with heart failure as in the CASTLE AF trial and others in a systematic review 
[127] are unlikely to become routine practice soon in this region. The same goes for VT ablations which are 
associated with significant morbidity, though not mortality, benefit [128].
Supraventricular tachycardias
Adult studies on SVTs in SSA remain largely non-existent except for one surgical case series on Wolff-Parkin-
son-White syndrome, with no palpable epidemiological data on AVNRT, pre-excitation syndromes with their 
associated orthodromic and antidromic AVRT, atrial tachycardia, inappropriate sinus tachycardia, and pos-
tural orthostatic tachycardia syndrome (POTS). The lack of electrophysiological expertise in almost all SSA 
countries except in South Africa, underscores this non-existent literature of SVTs. In Western World clinical 
studies, AVNRT accounts for about 55–60% of all SVTs, AVRT 25–30%, and AT 10–17% [123, 129], which is 
similar to what was seen in the only study in SSA. Most SVTs are very responsive to beta-blockers and non-
dihydropyridine calcium channel blockers which are generically cheap in SSA and will be useful once the 
diagnosis is confirmed. SVTs can lead to tachycardia-induced cardiomyopathy, atrial fibrillation, and SCD 
especially if people with pre-excitation develop AF/AFL [123, 130], and it is not unreasonable to speculate 
this as the etiology of some of the SCD seen in SSA. Emphasis on teaching, recognition, diagnosis, manage-
ment, clinical relevance, and awareness of these SVTs and other cardiac arrhythmias need to be enforced in 
medical schools and allied medical training programs across SSA.
Sudden cardiac arrest/sudden cardiac death
Given sparsity of structured Emergency Medical Services (EMS) and registries, the epidemiology of SCA/SCD 
is less characterized in SSA, apart from few data without supporting background for establishing reliable 
incidence estimates and etiologies. Both the internal and external validity of study results are affected by 
ascertainment of SCA/SCD cases. Data are more likely to reflect reality in the HIC with well-structured and 
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readily available EMS of within a few minutes from the cardiac arrest, compared to poorer regions of SSA 
where these services are only present in patches in some urban areas, but remain largely inexistent in rural 
areas. Thus reported incidences of OHCA in SSA of 6–34 cases per 100,000 inhabitants are lower than in 
Europe and North America, where incidences of EMS-assessed and EMS-treated OHCA are about 86–110 
per 100,000 and 40–57 per 100,000 respectively, and the presence of shockable rhythm (VT/VF) is seen 
in 20–35% of OHCA cases in adults and about 7% in children. In these regions, the incidence of IHCA var-
ies from 0.6–1.6 per 1000 inpatient bed-days (VT/VF 16.1%, PEA 52.3%, asystole 23.6%, unknown 8% in 
adults, while VT/VF was 10.7% in children) [123, 131].
This review identified underlying etiologies of SCA/SCD and ventricular arrhythmias in SSA, with hyper-
tensive heart disease, coronary disease, cardiomyopathy, including peripartum cardiomyopathy, and valvu-
lar heart disease, especially rheumatic heart disease being the most common causes of SCA/SCD among 
adults [61, 64, 67, 69, 71–73, 90]. Others include malignant arrhythmogenic inherited diseases [74–81, 
84–88, 102–104], pericarditis [92], endemic parasitic infections [9, 93], pulmonary embolism [62, 91], 
endomyocardial fibrosis [95], congenital heart disease [96], pulmonary embolism [62, 91], pulmonary 
hypertension [61], and aortic dissection/rupture [64]. Despite sarcoidosis being prevalent in SSA where 
approximately one in five cases is often mis-diagnosed as tuberculosis, studies on cardiac manifestations 
of sarcoidosis are lacking in this region [102–104]. However, it is known that African Americans in USA 
have a higher sarcoid incidence and >10 folds higher mortality including SCD and heart failure death 
compared to Caucasians [132]. Also, 5% of patients with sarcoidosis are known to have clinically mani-
fest cardiac involvement and another 20–25% have asymptomatic cardiac involvement, and these mani-
festations include cardiomyopathy leading to heart failure, VT/VF, and cardiac conduction disease [133]. 
In HIC, the most frequent cause of OHCA is CAD accounting for more than 50% of SCA/SCD cases [123], 
with autopsy studies showing 80% of adults who suffer SCD have severe CAD [134], and in 61% of OHCA, 
at least one significant coronary lesion deemed responsible for the OHCA was seen on angiography in 
adults [135]. Autopsy studies of SCD also show that 10–15% have dilated or hypertrophic cardiomyopa-
thy, and 5–10% have structurally normal hearts. About 30–50% of heart failure patients will die from 
SCD [134].
Cardiopulmonary resuscitation
This review identified very low CPR awareness even among physicians and low rates of CPR initiation in 
SSA. Compare this to HIC of Western Europe and North America where 40–45% of OHCA victims received 
bystander CPR, and where >60% of the general population are trained to perform CPR, and where all IHCA 
victims without prior ‘do not resuscitate’ (DNR) code are expected to have full attempt at resuscitation via 
CPR and advanced cardiac life support [123]. The critical importance of quality CPR on survival in SCA vic-
tims have been demonstrated [136], and 12.6% with versus 7.6% without bystander CPR survive to discharge 
in large Western World registries [123]. For every minute that passes between collapse and defibrillation, 
survival from witnessed VF SCA falls 7% to 10% if no CPR is provided and when bystander CPR is provided, 
the fall in survival is more gradual and averages 3% to 4% [137]. Pre-emptive strides to inculcate at least 
chest-compression and rescue breathing CPR to the masses, as well as setting-up EMS and maintaining 
acceptable standards, alongside building new or improving existing recipient hospitals in terms of cardiac 
professional expertise and cardiac equipment, should become priority in eyes of policy makers and stake-
holders within the health sector in SSA.
Bradyarrythmias and cardiac implantable electronic devices (CIEDs)
It is estimated that 1 million patients worldwide die annually because of a lack of bradyarrhythmia device 
therapy [138], and with low implant rates in SSA, it is less doubtful that this region is contributing abun-
dantly to this death pool. The rates of CIEDs implants in SSA are abysmally rock-bottom. For instance, Nige-
ria offers 0.2 implants per million population, which is >4000 times less than in Germany [12, 14, 139]. This 
means that many patients in this region with advanced bradyarrhythmias requiring pacemaker implanta-
tion are at the mercy of either succumbing to unbidden recurrent presyncope/syncope or premature sud-
den cardiac death. More than half (52%) of the patients identified as having an indication for pacing by 
visiting humanitarian pacing missions across 14 countries in SSA died before the missions arrived [110]. 
CAD and age-related degenerative conduction disease are the most common causes of AV block and SSS 
in HIC. The relatively low rates of CAD in SSA coupled with deaths from competitive causes at relatively 
younger age in SSA, could account for some of the low rates of pacemaker implantations in SSA. However, 
the approximately more than 200-fold lower rate of cardiac device implants compared to HIC of Western 
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Europe and North America might not be fully explained by these alone [11, 12]. That said, data from a few 
observational studies in the USA suggest lower risk of sick sinus syndrome in African Americans compared 
to Caucasians [140].
Post-mortem or reusable CIEDs
Three identified main barriers to pacemaker and ICD implantation in SSA are reduced availability of implant-
ing facilities with appropriate equipment, deficits in trained clinical specialists, and high cost of the devices 
and their accessories in the setting of high pay-out-of-pocket policies [9, 12, 106, 107, 141]. An interim solu-
tion to the high cost of cardiac devices is the re-use of previously implanted and explanted devices donated 
from the developed world, the so-called postmortem pacemakers and defibrillators, which have been shown 
to be safe in SSA [107, 116, 141, 142] and worldwide [138, 143], and their use has been backed by electro-
physiology specialists [144]. Despite earlier observation of underuse of these recycled cardiac devices in 
SSA [12], growing partnerships between PASCAR and My Heart Your Heart (University of Michigan, USA) as 
well as Pace 4 Life (UK-based charity organisation) are now helping to bring more of these reconditioned 
CIEDs to SSA [9, 141]. Given the palpable clear life-saving contribution of CIEDS, fostering partnerships and 
encouraging the re-use of CIEDS donated from the developed countries, plus initiatives aimed at building 
acceptable implanting centers and training specialists even through short and tailored fellowships [106], are 
of paramount importance and urgency.
Possible reasons for under-diagnosis and undertreatment of arrhythmias in SSA
Insufficient and skewed budget allocations
Encouraging member States of the African Region of the World Health Organization to meet the prescribed 
target of 15% of annual expenditure on health under the Abuja Declaration, as majority are still falling 
short, will help [145]. Also, balancing the currently skewed budget allocations appropriately between com-
municable disease and NCDs will be helpful [145, 146].
Insufficient health infrastructure including arrhythmia services
This review has observed deficiencies in health care systems and specialist cardiac services to manage CVDs 
[11, 12, 147, 148]. Therefore, patients who survive OHCA, for example, and reach hospitals in SSA have lower 
chances of survival compared to their high-income country counterparts where invasive investigations and 
treatments are now routine practice. Every country in SSA should strive to have at least one large tertiary 
referral academic center for treatment of CVDs and invasive treatment of arrhythmias. The development 
of cardiac arrhythmia services with available ECG machines, built-in cardiac rhythm monitoring systems 
and devices like Holter monitors, external loop and patch recorders, mobile cardiac telemetry (MCT), and 
implantable loop recorders, as well as trained professionals to interpret their findings are warranted in order 
to diagnose arrhythmias in SSA.
Scarcity of cardiac professionals including electrophysiologists
There is a very low proportion of physicians to population, with majority of SSA countries having <5 phy-
sicians per 10,000 people [149], and 18% of the sub-Saharan African countries in a survey did not have a 
registered cardiologist, let alone a cardiac electrophysiologist [11, 12]. The paucity of good training programs 
for cardiologists in SSA is compounded by the difficulty of African-trained physicians to get into good car-
diology training fellowship programs in the western world, as cardiology is a highly attractive sub-specialty 
for which entry is usually fairly competitive even for western-trained physicians within their own respective 
countries. International and regional training partnerships should be fostered, like the PASCAR Fellowship 
in cardiac pacing which has already trained some fellows from countries where no pacing was present, and 
other regional initiatives [150].
Hight cost of arrhythmia management compounded by rarity of health insurance systems
Management of CVDs can very expensive [123]. CIEDs are very costly and unfordable by majority of the 
population in SSA, where direct out-of-pocket payments as a share of total health expenditure are still 
>40%, often leading to impoverishment [146]. This is compounded by the rarity of national health insur-
ance systems, available in only about 15% of 55 African countries [149]. Development of these insurance 
systems should be encouraged and should become salient schemes in public health and financial planning 
within countries. An inclusive universal healthcare system with national-level health insurance scheme is 
probably better as it will avoid the poorer population from being left behind.
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Inadequate epidemiological data
This review has noted very sparse data on SVTs, ventricular arrhythmias, and bradyarrhythmias. Poor ascer-
tainment and capture of the true burden and trends of arrythmias and other CVDs might lead to under-
estimated disease rates and distort public health planning. Efforts should be made by governments and 
academic institutions through funding to remedy this handicap.
Limitations
As recommended in PRISMA-P guidelines, classical publication databases such as PubMed/MEDLINE and 
EMBASE were used to retrieve the information. The databases used were supplemented by a database focused 
on African publication (AJOL). Furthermore, in order to capture any grey publication, some manual searches 
were conducted on internet and bibliography of published articles. Although, this wide variety of sources 
provide an accurate picture of the cardiac arrhythmias in sub-Saharan Africa, it comes with several challenges. 
Firstly, the clinical heterogeneity materialized, for instance, by marked differences observed in how studies 
were designed, differences in participants (age), comorbidities assessed, and treatment availability (Tables 
1, 2, and 4). Secondly, the statistical heterogeneity characterized by how findings were reported precluded a 
meta-analysis. Although search criteria which combine the names of all sub-Saharan African countries was an 
option, we believe relevant arrhythmia studies in this region were not missed with the criteria used.
Conclusions
The SSA region appears unprepared for the growing burden of arrhythmias, which appear to be under-
diagnosed and undertreated. While victims of OHCA arrest in this region have low chances of ROSC and 
survival due to lack of CPR awareness and shortage of EMS, survivors to hospital also have lower survival 
rates due to sparsity of invasive cardiac procedures like coronary angiography, primary PCI, pacemakers, 
defibrillators, and antiarrhythmic medications. On the other hand, the majority of the tachyarrhythmias are 
managed conservatively due to low rates of invasive cardiac electrophysiological procedures in SSA, as set-
ting-up health systems for their management is usually very expensive. Thus, to reduce morbidity and mor-
tality from arrhythmias, high level strategic planning is needed, involving governmental, non-governmental 
organizations, international organizations, societies and associations, and local stakeholders.
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